Corpus Intelligence IC Memo — PAM REHAB HOSPITAL OF DOVER 2026-04-26 02:17 UTC
IC Memo — PAM REHAB HOSPITAL OF DOVER
Investment Committee Memorandum | DE | 34 beds | Grade D | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PAM REHAB HOSPITAL OF DOVER

CCN 083027 | KENT, DE | 34 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PAM REHAB HOSPITAL OF DOVER is a 34-bed community hospital in KENT, DE with $27.2M in net patient revenue and a 28.0% operating margin. The hospital serves a payer mix of 79.5% Medicare, 0.0% Medicaid, and 20.5% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.0% to 35.3% (+736bps).

Net Revenue HCRIS$27.2M
Current EBITDA COMPUTED$7.6M
Operating Margin COMPUTED28.0%
Occupancy HCRIS96.7%
Revenue / Bed COMPUTED$800K
Net-to-Gross HCRIS62.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

14
DE Hospitals
0.7%
State Median Margin
2635
Comparable Hospitals

DE has 14 Medicare-certified hospitals with a median operating margin of 0.7%. The target's margin of 28.0% places it above the state median. Among 2635 size-comparable peers (17-68 beds), the median margin is -5.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (17-68), prioritizing same-state peers. 2635 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PAM REHAB HOSPITAL OF DOVER (Target)DE34$27.2M28.0%
DANA-FARBER CANCER INSTITUTEMA30$1.88B-35.1%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
LAKEVIEW MEMORIALMN68$411.9M60.9%
MOUNTAIN VIEW HOSPITALID43$382.5M8.7%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$571K+210bp18mo
Cost to Collect4.5%2.5%$544K+200bp12mo
Denial Rate Reduction12.0%6.5%$539K+198bp12mo
A/R Days Reduction5200.0%3800.0%$331K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$571K
Cost to Collect
$544K
Denial Rate Reduction
$539K
A/R Days Reduction
$331K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$7.6M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$9.6M
Current Margin28.0%
Pro Forma Margin35.3%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.7M$70.3M6.00x43.1%
Base (11x exit)10.0x11.0x$11.7M$81.1M6.92x47.2%
Bull Case9.0x11.0x$10.5M$91.5M8.68x54.1%
Bull (12x exit)9.0x12.0x$10.5M$102.9M9.76x57.7%
Bear Case11.0x10.0x$12.9M$56.4M4.38x34.4%
Bear (11x exit)11.0x11.0x$12.9M$66.3M5.14x38.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 79.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 2635 hospitals with 17-68 beds
  • Same-state prioritization (n=3)
  • Comp margins: P25=-17.7% / P50=-5.3% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.